Electrochemical-Based Biosensors: New Diagnosis Platforms for Cardiovascular Disease

Curr Med Chem. 2020;27(15):2550-2575. doi: 10.2174/0929867326666191024114207.

Abstract

One of the major reasons for mortality throughout the world is cardiovascular diseases. Therefore, bio-markers of cardiovascular disease are of high importance to diagnose and manage procedure. Detecting biomarkers provided a promising procedure in developing bio-sensors. Fast, selective, portable, accurate, inexpensive, and sensitive biomarker sensing instruments will be necessary for detecting and predicting diseases. One of the cardiac biomarkers may be ordered as C-reactive proteins, lipoprotein-linked phospho-lipase, troponin I or T, myoglobin, interleukin-6, interleukin-1, tumor necrosis factor alpha, LDL and myeloperoxidase. The biomarkers are applied to anticipate cardio-vascular illnesses. Initial diagnoses of these diseases are possible by several techniques; however, they are laborious and need costly apparatus. Current researches designed various bio-sensors for resolving the respective issues. Electrochemical instruments and the proposed bio-sensors are preferred over other methods due to its inexpensiveness, mobility, reliability, repeatability. The present review comprehensively dealt with detecting biomarkers of cardiovascular disease through electro-chemical techniques.

Keywords: C reactive proteins; Cardiovascular disease; diagnosis; electrochemical biosensors; mortality; myeloperoxidase..

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Biosensing Techniques*
  • Cardiovascular Diseases*
  • Electrochemical Techniques
  • Humans
  • Reproducibility of Results

Substances

  • Biomarkers